完整标题：WHO Statement on Solidarity Trial Vaccines
发稿单位：WHO(世界卫生组织)
发稿时间：26 October 2021
撰 稿 者：同发稿单位
原文连结：https://bit.ly/3pC2Qyz
WHO and the Ministries of Health of Colombia, Mali, and the Philippines
announce the launch of the co-sponsored Solidarity Trial Vaccines.
关于Solidarity Trail的进一步介绍：https://bit.ly/3jEEQXL
WHO将会资助哥伦比亚卫生部、马利卫生部、菲律宾卫生部进行团体疫苗试验
This is an international, randomized clinical trial platform designed to
rapidly evaluate the efficacy and safety of promising new candidate vaccines
selected by an independent vaccine prioritization advisory group composed of
leading scientists and experts.
这是一个国际性、随机性临床试验平台，目的是
经由专业人士和科学家组成的独立疫苗专家小组选择新的候选疫苗
并尽快评估安全性和有效性
This announcement comes after the relevant regulatory authorities and ethics
committees have granted approval for the study to progress.
The national principal investigators and their research teams in Colombia,
Mali, and the Philippines have begun recruiting volunteers joining the trial.
本次声明经由当地相关法律单位和伦理审议委员会审核通过后提出。
临床试验主负责人和所属研究团队开始应征受试者做临床试验。
The Solidarity Trial Vaccines is beginning with research teams in over 40
trial sites spread across the three countries. National research teams bring
together experienced investigators well-versed in good clinical practice and
the conduct of clinical trials.
团体疫苗试验将会在三个国家、共40个临床试验点进行临床试验。
(National research那一句讲会做好临床试验但我不太会翻)
To date, the independent vaccine prioritization advisory group has reviewed
the evidence of around 20 candidate vaccines. Following the recommendation of
the working group, 2 candidate vaccines are now included in the Solidarity
Trial Vaccines. These are a protein subunit vaccine from Medigen, and a DNA
vaccine encoding the spike protein from Inovio.
到目前为止，独立疫苗专家小组已经确认约20个候选疫苗的相关证据
经小组建议，把高端的次蛋白疫苗和Inovio的DNA疫苗加入团体疫苗试验
Two additional vaccines are expected to enter the Solidarity Trial Vaccines
once additional evidence and documentation has been reviewed and accepted as
satisfactory by the independent vaccine prioritization advisory group.
It is expected that other candidate vaccines currently under consideration by
the vaccine prioritization advisory group may be added to the trial in late
2021 and during 2022.
只要相关证据都能证明的话，预期2021年底至2022年还会再加入2支候选疫苗
The Solidarity Trial Vaccines aims to accelerate the evaluation of multiple
promising candidate COVID-19 vaccines, contributing to the creation of a
larger portfolio of vaccines needed to protect people from COVID-19 around
the world. The trial has the additional potential to uncover
second-generation vaccines with greater efficacy, conferring greater
protection against variants of concern, offering longer duration of
protection, and/or using needle-free routes of administration.
(团体疫苗试验的声明和目标 整段省略不提应该可以吧....0_0?)